Trial Details
COMPLETEDBasic Information
| Clinical ID | c255 |
|---|---|
| Identifier | NCT04982172 |
| Trial Title | Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Infliximab|DRUG: Infliximab |
Participant Information
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
|---|---|
| City | Leuven |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2022-02-08 |
|---|---|
| Primary Completion Date | 2022-11-01 |
| Completion Date | 2023-02-01 |